20/20 Biolabs Files Prospectus Supplement
Ticker: AIDX · Form: 424B3 · Filed: Apr 28, 2026 · CIK: 0001139685
| Field | Detail |
|---|---|
| Company | 20/20 Biolabs, Inc. (AIDX) |
| Form Type | 424B3 |
| Filed Date | Apr 28, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: prospectus-supplement, securities-offering, testing-laboratories
TL;DR
20/20 Biolabs filed a prospectus supplement on 4/28/26. Keep an eye on their next move.
AI Summary
20/20 Biolabs, Inc. filed a prospectus supplement (424B3) on April 28, 2026, related to its securities. The filing details the company's business address in Rockville, MD, and its mailing address in Gaithersburg, MD. The company is classified under Services-Testing Laboratories.
Why It Matters
This filing indicates that 20/20 Biolabs is actively managing its securities offerings, which could impact its capital structure and future business operations.
Risk Assessment
Risk Level: low — This is a routine prospectus supplement filing, not indicating immediate financial distress or significant new risks.
Key Numbers
- 424B3 — Form Type (Indicates a prospectus supplement filing)
Key Players & Entities
- 20/20 Biolabs, Inc. (company) — Filer of the 424B3 prospectus supplement
- 0001139685 (company) — CIK number for 20/20 Biolabs, Inc.
- 2026-04-28 (date) — Filing date of the 424B3 prospectus supplement
FAQ
What specific securities are being supplemented by this 424B3 filing?
The filing is a prospectus supplement (Form 424B3) filed by 20/20 Biolabs, Inc. on April 28, 2026. Specific details about the securities are not provided in the excerpt, but it relates to their ongoing securities offerings.
What is the primary business of 20/20 Biolabs, Inc. according to the filing?
According to the filing, 20/20 Biolabs, Inc. operates in the Services-Testing Laboratories sector (SIC code 8734).
Where are the business and mailing addresses for 20/20 Biolabs, Inc.?
The business address is 9430 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850, and the mailing address is 15810 GAITHER ROAD, SUITE 235 GAITHERSBURG MD 20877.
When was this prospectus supplement accepted by the SEC?
The prospectus supplement was accepted by the SEC on April 28, 2026, at 07:57:35.
What is the CIK number for 20/20 Biolabs, Inc.?
The CIK number for 20/20 Biolabs, Inc. is 0001139685.
Filing Details
This Form 424B3 (Form 424B3) was filed with the SEC on April 28, 2026 regarding 20/20 Biolabs, Inc. (AIDX).